High Flow Oxygen Therapy Devices Market

High Flow Oxygen Therapy Devices Market (Product Type: Portable Devices, Standalone Devices, and Accessories; Application: Lung Cancer, COPD, Asthma, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

High Flow Oxygen Therapy Devices Market Outlook 2031

  • The global industry was valued at US$ 1.7 Bn in 2022
  • It is projected to record a CAGR of -2.4% from 2023 to 2031 and reach US$ 1.4 Bn by the end of 2031

Analysts’ Viewpoint

Rise in prevalence of chronic diseases is expected to augment the global high flow oxygen therapy devices market during the forecast period. High flow oxygen therapy device is a type of respiratory support that provides high flow of oxygen-enriched air to patients having difficulty in breathing. Technological advancements in high-flow oxygen therapy equipment, such as compact design, portability, and improved patient comfort features, are driving market growth.

R&D of new devices is likely to offer lucrative opportunities to market players. Leading companies are launching advanced devices in order to increase their high flow oxygen therapy devices market share. However, high cost, lack of trained healthcare personnel, and patient discomfort are anticipated to hamper market statistics during the forecast period.

High Flow Oxygen Therapy Devices Market

High Flow Oxygen Therapy Devices Market Introduction

High flow oxygen therapy is a medical treatment that involves delivery of supplemental oxygen to a patient through a device that increases the flow and humidity of the oxygen. This therapy is used to treat patients with chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and bronchial asthma, as well as Acute Respiratory Distress Syndrome (ARDS). High flow oxygen therapy devices are available in two types: portable and standalone.

Rise in Prevalence of Chronic Respiratory Diseases

Increase in prevalence of chronic respiratory diseases is driving the global high flow oxygen therapy devices industry. Incidence of chronic respiratory diseases, such as COPD and asthma, is rising across the globe.

According to the World Health Organization (WHO), chronic respiratory disease was the third leading cause of death across the world in 2021. Around 65 million people globally have moderate to severe COPD.

Asthma affects an estimated 334 million people across the world, and the number is expected to increase in the next few years. Smoking is another significant factor driving the prevalence of chronic respiratory diseases. According to the WHO, tobacco smoking is the leading cause of COPD. It is also a major risk factor for the development of asthma. Furthermore, surge in usage of biomass fuels, such as wood and dung, for cooking and heating in low-income countries is boosting the prevalence of chronic respiratory diseases.

Technological Advancements Augmenting Global High Flow Oxygen Therapy Devices Market Size

Innovations in design and functionality have made high flow oxygen therapy devices more user-friendly, portable, and efficient. Development of continuous flow systems is a key technological advancement that has accelerated market expansion. These systems provide constant flow of oxygen, which makes them ideal for patients with severe respiratory distress. Continuous flow systems have also been designed to be more compact and lightweight, and are ideal devices for usage in home-based healthcare and during transport.

Development of hybrid systems that combine high flow oxygen with non-invasive positive pressure ventilation (NIPPV) is another breakthrough technological advancement in the market. This combination allows for improved oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS), thereby reducing the risk of intubation and mechanical ventilation.

Higher and Efficient Flow of Oxygen Using Accessories

In terms of product type, the accessories segment held leading share of the global high flow oxygen therapy devices market in 2022. Rise in prevalence of chronic respiratory diseases is likely to drive the segment during the forecast period. Accessories of high flow oxygen therapy devices include nasal cannula and mask.

High flow nasal cannulas deliver heated and humidified oxygen to patient through a nasal cannula. These are designed to provide higher flow of oxygen than traditional humidified oxygen nasal cannulas and are used in the treatment of a range of respiratory conditions, including COPD, asthma, and pneumonia. Usage of high flow nasal cannulas has increased in the last few years due to their ability to deliver oxygen more efficiently and comfortably than traditional nasal cannulas.

High flow oxygen masks are used to treat patients with severe respiratory distress. They are often used in conjunction with non-invasive positive pressure ventilation (NIPPV). High flow oxygen masks have also become more popular in the past few years due to advancements in technology that have made these devices more user-friendly and efficient.

Increase in Number of Cases of Lung Cancer

Based on application, the lung cancer segment is likely to account for major share of the global high flow oxygen therapy devices market during the forecast period. Lung cancer is the leading cause of cancer deaths worldwide, accounting for approximately one in four cancer deaths.

Increase in number of cases of lung cancer, rise in global population, and aging population are expected to drive the demand for lung cancer treatment. Additionally, advancements in treatment options, such as targeted therapy and immunotherapy, which have improved patient outcomes, are expected to bolster the segment in the next few years.

Regional Outlook of Global High Flow Oxygen Therapy Devices Market

North America held the largest share of around 35.0% of the global high flow oxygen therapy devices market demand in 2022. The region is projected to be a highly lucrative market during the forecast period. North America's global dominance can be ascribed to the increase in incidence chronic diseases. The U.S. dominated the market in the region owing to factors such as presence of leading players and increase in research & development activities in high flow oxygen therapy devices.

Asia Pacific is projected to be the fastest growing market for high flow oxygen therapy devices during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2022 to 2031 due to high incidence rate and increasing population.

Analysis of Key Players

The global high flow oxygen therapy devices market is fragmented, with the presence of large number of players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by the leading players.

GE HealthCare, Koninklijke Philips N.V, ResMed, Fisher & Paykel Healthcare, Hamilton Medical, Besmed Health Business Corp, Linde Healthcare, BMC Medical, Movair, and VYAIRE Medical are the prominent players operating in the market.

Key Developments in Global High Flow Oxygen Therapy Devices Market

  • In October 2021, Movair, formerly known as International Biophysics Corporation, introduced Luisa, an advanced ventilator designed for usage in homes, institutions, hospitals, or portable applications for both invasive and non-invasive ventilation. In response to the growing demand for safe and effective ventilators, Luisa is now available through the FDA's Emergency Use Authorization. It is a portable and compact home ventilator that is available in the U.S. It is one of the first to offer high flow oxygen therapy.
  • In August 2020, Nocca Robotics Pvt. Ltd, an IIT Kanpur incubate company, launched the Noccarc H210 High-Flow Oxygen Therapy Device. The advanced device has been shown to be effective in the treatment of COVID-19 patients. It is simple to use and comfortable for patients. High flow oxygen therapy significantly reduces the likelihood of intubation.

Each of these players has been profiled in the high flow oxygen therapy devices market report based on parameters such as company overview, strategies, portfolio, segments, and recent developments.

Global High Flow Oxygen Therapy Devices Market Snapshot

Attribute

Detail

Size in 2022

US$ 1.7 Bn

Forecast (Value) in 2031

More than US$ 1.4 Bn

Growth Rate (CAGR)

-2.4%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product Type
    • Portable Devices
    • Standalone Devices (Reservoir)
    • Accessories
      • High-flow Nasal Cannula
      • High-flow Face Mask (HFFM)
      • Respiratory Humidifier
      • Others
  • Application
    • Lung Cancer
    • COPD
    • Asthma
    • Heart Failure
    • Others
  • End-user
    • Hospitals
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle east and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • GE HealthCare
  • Koninklijke Philips N.V
  • ResMed
  • Fisher & Paykel healthcare
  • Hamilton Medical
  • Besmed Health Business Corp
  • Linde Healthcare
  • BMC Medical
  • VYAIRE Medical
  • Movair

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global high flow oxygen therapy devices market in 2022?

The global industry was valued at US$ 1.7 Bn in 2022

How big will it be in 2031?

It is projected to reach more than US$ 1.4 Bn by 2031

What will be the CAGR during the forecast period?

The CAGR is anticipated to be -2.4% from 2023 to 2031

Which are the prominent trends that affect growth?

Rise in prevalence of chronic diseases and technological advancements

Which region will account for major share?

North America is likely to account for leading share during the forecast period

Who are the prominent players in the business?

GE HealthCare, Koninklijke Philips N.V, ResMed, Fisher & Paykel Healthcare, Hamilton Medical, Besmed Health Business Corp, Linde Healthcare, BMC Medical, Movair, and VYAIRE Medical

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global High Flow Oxygen Therapy Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Technological Advancements

        5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

        5.3. Key Product/Brand Analysis

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

    6. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Portable Devices

            6.3.2. Standalone Devices (Reservoir)

            6.3.3. Accessories

                6.3.3.1. High-flow Nasal Cannula

                6.3.3.2. High-flow Face Mask (HFFM)

                6.3.3.3. Respiratory Humidifier

                6.3.3.4. Others

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Lung Cancer

            7.3.2. COPD

            7.3.3. Asthma

            7.3.4. Heart Failure

            7.3.5. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Specialty Clinics

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America High Flow Oxygen Therapy Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Portable Devices

            10.2.2. Standalone Devices (Reservoir)

            10.2.3. Accessories

                10.2.3.1. High-flow Nasal Cannula

                10.2.3.2. High-flow Face Mask (HFFM)

                10.2.3.3. Respiratory Humidifier

                10.2.3.4. Others

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Lung Cancer

            10.3.2. COPD

            10.3.3. Asthma

            10.3.4. Heart Failure

            10.3.5. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Specialty Clinics

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe High Flow Oxygen Therapy Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Portable Devices

            11.2.2. Standalone Devices (Reservoir)

            11.2.3. Accessories

                11.2.3.1. High-flow Nasal Cannula

                11.2.3.2. High-flow Face Mask (HFFM)

                11.2.3.3. Respiratory Humidifier

                11.2.3.4. Others

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Lung Cancer

            11.3.2. COPD

            11.3.3. Asthma

            11.3.4. Heart Failure

            11.3.5. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Specialty Clinics

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific High Flow Oxygen Therapy Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Portable Devices

            12.2.2. Standalone Devices (Reservoir)

            12.2.3. Accessories

                12.2.3.1. High-flow Nasal Cannula

                12.2.3.2. High-flow Face Mask (HFFM)

                12.2.3.3. Respiratory Humidifier

                12.2.3.4. Others

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Lung Cancer

            12.3.2. COPD

            12.3.3. Asthma

            12.3.4. Heart Failure

            12.3.5. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Specialty Clinics

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America High Flow Oxygen Therapy Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Portable Devices

            13.2.2. Standalone Devices (Reservoir)

            13.2.3. Accessories

                13.2.3.1. High-flow Nasal Cannula

                13.2.3.2. High-flow Face Mask (HFFM)

                13.2.3.3. Respiratory Humidifier

                13.2.3.4. Others

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Lung Cancer

            13.3.2. COPD

            13.3.3. Asthma

            13.3.4. Heart Failure

            13.3.5. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Specialty Clinics

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa High Flow Oxygen Therapy Devices Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Portable Devices

            14.2.2. Standalone Devices (Reservoir)

            14.2.3. Accessories

                14.2.3.1. High-flow Nasal Cannula

                14.2.3.2. High-flow Face Mask (HFFM)

                14.2.3.3. Respiratory Humidifier

                14.2.3.4. Others

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Lung Cancer

            14.3.2. COPD

            14.3.3. Asthma

            14.3.4. Heart Failure

            14.3.5. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Specialty Clinics

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2022

        15.3. Company Profiles

            15.3.1. GE HealthCare

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Koninklijke Philips N.V

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. ResMed

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Fisher & Paykel Healthcare

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Hamilton Medical

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

            15.3.6. Besmed Health Business Corp

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

            15.3.7. Linde Healthcare

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

            15.3.8. BMC Medical

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

            15.3.9. VYAIRE Medical

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

            15.3.10. Movair

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Product Portfolio

                15.3.10.3. Financial Overview

                15.3.10.4. SWOT Analysis

    List of Tables

    Table 01: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 07: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global High Flow Oxygen Therapy Devices Market Value Share, by Product Type (2022)

    Figure 03: Global High Flow Oxygen Therapy Devices Market Value Share, by End-user (2022)

    Figure 04: Global High Flow Oxygen Therapy Devices Market Value Share, by Application (2022)

    Figure 05: Global High Flow Oxygen Therapy Devices Market Value Share, by Region (2022)

    Figure 06: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 07: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 08: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 09: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 10: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 11: Global High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 12: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Region, 2022 and 2031

    Figure 13: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Region, 2022-2031

    Figure 14: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 15: North America High Flow Oxygen Therapy Devices Market Value Share (%), by Country, 2022 and 2031

    Figure 16: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Country, 2023–2031

    Figure 17: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 18: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 19: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 20: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 21: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 22: North America High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 23: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 24: Europe High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031

    Figure 25: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031

    Figure 26: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 27: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 28: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 29: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 30: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 31: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 32: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 33: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031

    Figure 34: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031

    Figure 35: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 36: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 37: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 38: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 39: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 40: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 41: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 42: Latin America High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031 

    Figure 43: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031

    Figure 44: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031 

    Figure 45: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 46: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031 

    Figure 47: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 48: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 49: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 50: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 51: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031

    Figure 52: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031

    Figure 53: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 54: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031

    Figure 55: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 56: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031

    Figure 57: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 58: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031

    Figure 59: Global High Flow Oxygen Therapy Devices Market Share Analysis, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved